The report focuses on the Ankylosing Spondylitis market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Ankylosing Spondylitis market.
Major Players in the Ankylosing Spondylitis market are:
Merck & Co.
Shanghai Pharmaceuticals
UCB
Pfizer
Sanofi
Eisai
Celltrion
Bristol-Myers Squibb
Otsuka Pharmaceutical
Celgene
Novartis
Merck Sharp & Dohme
Boehringer Ingelheim
Amgen
Abbvie
Regeneron Pharmaceuticals
Janssen Pharmaceuticals
F. Hoffmann-La Roche
On the basis of types, the Ankylosing Spondylitis market is primarily split into:
TNF Inhibitors
COX Inhibitors
Others
On the basis of applications, the market covers:
Oral
Parenteral
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Ankylosing Spondylitis Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Ankylosing Spondylitis Market Overview
1.1 Product Overview and Scope of Ankylosing Spondylitis Market
1.2 Ankylosing Spondylitis Market Segment by Type
1.2.1 Global Ankylosing Spondylitis Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Ankylosing Spondylitis Market Segment by Application
1.3.1 Ankylosing Spondylitis Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Ankylosing Spondylitis Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Ankylosing Spondylitis (2017-2029)
1.5.1 Global Ankylosing Spondylitis Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Ankylosing Spondylitis Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Ankylosing Spondylitis Industry
1.7 Impact of Carbon Neutrality on the Ankylosing Spondylitis Industry
2 Ankylosing Spondylitis Market Upstream and Downstream Analysis
2.1 Ankylosing Spondylitis Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Ankylosing Spondylitis Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Merck & Co.
3.1.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Shanghai Pharmaceuticals
3.2.1 Shanghai Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.2.4 Business Overview
3.3 UCB
3.3.1 UCB Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Pfizer
3.4.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Sanofi
3.5.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Eisai
3.6.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Celltrion
3.7.1 Celltrion Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Bristol-Myers Squibb
3.8.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Otsuka Pharmaceutical
3.9.1 Otsuka Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Celgene
3.10.1 Celgene Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Novartis
3.11.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Merck Sharp & Dohme
3.12.1 Merck Sharp & Dohme Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Boehringer Ingelheim
3.13.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Amgen
3.14.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Abbvie
3.15.1 Abbvie Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Regeneron Pharmaceuticals
3.16.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Janssen Pharmaceuticals
3.17.1 Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.17.4 Business Overview
3.18 F. Hoffmann-La Roche
3.18.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Ankylosing Spondylitis Market Performance (2017-2022)
3.18.4 Business Overview
4 Global Ankylosing Spondylitis Market Landscape by Player
4.1 Global Ankylosing Spondylitis Sales and Share by Player (2017-2022)
4.2 Global Ankylosing Spondylitis Revenue and Market Share by Player (2017-2022)
4.3 Global Ankylosing Spondylitis Average Price by Player (2017-2022)
4.4 Global Ankylosing Spondylitis Gross Margin by Player (2017-2022)
4.5 Ankylosing Spondylitis Market Competitive Situation and Trends
4.5.1 Ankylosing Spondylitis Market Concentration Rate
4.5.2 Ankylosing Spondylitis Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Ankylosing Spondylitis Sales, Revenue, Price Trend by Type
5.1 Global Ankylosing Spondylitis Sales and Market Share by Type (2017-2022)
5.2 Global Ankylosing Spondylitis Revenue and Market Share by Type (2017-2022)
5.3 Global Ankylosing Spondylitis Price by Type (2017-2022)
5.4 Global Ankylosing Spondylitis Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Ankylosing Spondylitis Sales, Revenue and Growth Rate of TNF Inhibitors (2017-2022)
5.4.2 Global Ankylosing Spondylitis Sales, Revenue and Growth Rate of COX Inhibitors (2017-2022)
5.4.3 Global Ankylosing Spondylitis Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global Ankylosing Spondylitis Market Analysis by Application
6.1 Global Ankylosing Spondylitis Consumption and Market Share by Application (2017-2022)
6.2 Global Ankylosing Spondylitis Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Ankylosing Spondylitis Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Ankylosing Spondylitis Consumption and Growth Rate of Oral (2017-2022)
6.3.2 Global Ankylosing Spondylitis Consumption and Growth Rate of Parenteral (2017-2022)
7 Global Ankylosing Spondylitis Sales and Revenue Region Wise (2017-2022)
7.1 Global Ankylosing Spondylitis Sales and Market Share, Region Wise (2017-2022)
7.2 Global Ankylosing Spondylitis Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Ankylosing Spondylitis Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Ankylosing Spondylitis Market Forecast (2022-2029)
8.1 Global Ankylosing Spondylitis Sales, Revenue Forecast (2022-2029)
8.1.1 Global Ankylosing Spondylitis Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Ankylosing Spondylitis Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Ankylosing Spondylitis Price and Trend Forecast (2022-2029)
8.2 Global Ankylosing Spondylitis Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.3 China Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.5 India Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Ankylosing Spondylitis Sales and Revenue Forecast (2022-2029)
8.3 Global Ankylosing Spondylitis Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Ankylosing Spondylitis Revenue and Growth Rate of TNF Inhibitors (2022-2029)
8.3.2 Global Ankylosing Spondylitis Revenue and Growth Rate of COX Inhibitors (2022-2029)
8.3.3 Global Ankylosing Spondylitis Revenue and Growth Rate of Others (2022-2029)
8.4 Global Ankylosing Spondylitis Consumption Forecast by Application (2022-2029)
8.4.1 Global Ankylosing Spondylitis Consumption Value and Growth Rate of Oral (2022-2029)
8.4.2 Global Ankylosing Spondylitis Consumption Value and Growth Rate of Parenteral (2022-2029)
8.5 Ankylosing Spondylitis Market Forecast Under COVID-19
9 Industry Outlook
9.1 Ankylosing Spondylitis Market Drivers Analysis
9.2 Ankylosing Spondylitis Market Restraints and Challenges
9.3 Ankylosing Spondylitis Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Ankylosing Spondylitis Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Ankylosing Spondylitis Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Ankylosing Spondylitis Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Ankylosing Spondylitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 110
Market Overview of Global Ankylosing Spondylitis market:
According to our latest research, the global Ankylosing Spondylitis market looks promising in the next 5 years. As of 2022, the global Ankylosing Spondylitis market was estimated at USD 5633.32 million, and it's anticipated to reach USD 9003.47 million in 2028, with a CAGR of 8.13% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
Global Osteoarthritis Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Dec-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Osteoarthritis Treatment market:
According to our latest research, the global Osteoarthritis Treatment market looks promising in the next 5 years. As of 2022, the global Osteoarthritis Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
Global Viscosupplementation Market Research Report 2023
Published: 11-Oct-2023 Price: US 2900 Onwards Pages: 92
Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms.
According to QYResearch's new survey, global Viscosupplementation market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctua......
Global Psoriatic Arthritis Market 2023
Published: 01-Sep-2023 Price: US 3350 Onwards Pages: 91
Description
The global market for psoriatic arthritis treatment is projected to reach USD 12.72 billion by 2029, growing at a CAGR of 6.1% from USD 8.27 billion in 2022. Psoriatic arthritis is a chronic inflammatory rheumatic disease that affects up to 30% of psoriasis patients aged 30 to 60. It is more common in women. The exact cause is unknown, but family history and certain risk factors play a role. Diagnosis involves imaging techniques and symptom evaluation. Treatment options include......
Global Tinea Pedis Treatment Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 114
Fungal foot-animal, known medically as tinea pedis, is a common skin infection of the feet caused by fungus. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes.
In this report, we study the drugs for Fungal foot-animal.
The global Tinea Pedis Treatment market is projected to grow from US$ 1230 million in 2023 to US$ 1520.8 mi......
Global Osteoarthritis Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 10-Aug-2023 Price: US 3260 Onwards Pages: 100
The Osteoarthritis Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Osteoarthritis Treatment industry, and breaks down according to the type, application, and consumption area of Osteoarthritis Treatment. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
Global Osteoarthritis Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 01-Aug-2023 Price: US 3260 Onwards Pages: 102
The Osteoarthritis market revenue was 7668.26 Million USD in 2022, and will reach 14182.81 Million USD in 2028, with a CAGR of 10.79% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Osteoarthritis industry, and breaks down according to the type, application, and consumption area of Osteoarthritis. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes......
Global Viscosupplementation Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 27-Jul-2023 Price: US 3260 Onwards Pages: 104
The Viscosupplementation market revenue was 2579.17 Million USD in 2022, and will reach 3483.24 Million USD in 2028, with a CAGR of 5.14% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Viscosupplementation industry, and breaks down according to the type, application, and consumption area of Viscosupplementation. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
Global Ankylosing Spondylitis Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 22-Jun-2023 Price: US 3260 Onwards Pages: 99
The Ankylosing Spondylitis market revenue was 5633.32 Million USD in 2022, and will reach 9003.47 Million USD in 2028, with a CAGR of 8.13% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Ankylosing Spondylitis industry, and breaks down according to the type, application, and consumption area of Ankylosing Spondylitis. The report also introduces players in the industry from the perspective of the industry chain and marketi......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs